The second round of recruitment is underway for the Phase 2a trial led by Brisbane-located Queensland University of Technology (QUT).
This trial has already involved 32 people who experience depression and more volunteers are being sought as QUT and Medlab aim for estimated total participant numbers of 150.
Depression a global issue
The Phase 2a trial has been designed to meet TGA requirements for expedited drug approval.
Globally, more than 300 million people suffer from depression and in Australia, 45% of people aged 16-85 years have met the criteria for a diagnosis of a mental disorder at some point in their lives.
Depression, as a part of mental health, is an Australian health priority.
Principal investigator of the trial, clinical psychologist Dr